Patterson Companies gains on Nasdaq delisting for sale to Patient Square
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 11 2025
0mins
Should l Buy ?
Source: SeekingAlpha
Patterson Companies Stock Movement: Patterson Companies saw a 1.1% increase in after-hours trading following a Nasdaq delisting notice related to its acquisition by Patient Square Capital, which is expected to close before market opening on Thursday.
Debt Financing Delay: The stock had previously dropped 0.9% due to reports of delays in the $2.35 billion debt financing for the acquisition amid recent market volatility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
